GCSE Biology Infection and Response Study Guide

Communicable Diseases and Pathogens

Communicable diseases are infectious conditions that can spread from person to person or between organisms. Pathogens are the micro-organisms or biological agents responsible for causing these diseases.

There are four main types of pathogens:

• Bacteria

• Viruses

• Fungi

• Protists

Pathogens are transmitted between hosts through several environmental mechanisms. While standard biology texts document up to five total transmission pathways, the primary three pathways are:

• Water

• Air

• Direct contact

Detailed Characteristics of Pathogen Types

Bacteria

• Bacteria are very small, single-celled biological organisms.

• Once inside a host, bacteria reproduce rapidly and produce harmful chemical toxins.

• These toxins damage host cells and tissues, causing the symptoms associated with bacterial illness.

• Primary examples of bacterial pathogens include:

  • Salmonella

  • Gonorrhea

Viruses

• Viruses are not cellular structures.

• They require a host organism to function, invading host body cells and utilizing cellular machinery to replicate inside them.

• As viruses reside inside host cells and are non-cellular, antibiotics are entirely ineffective against viral infections.

• Primary examples of viral pathogens include:

  • Measles

  • HIV (Human Immunodeficiency Virus)

Fungi

• Fungal pathogens can exist as single-celled organisms or multicellular organisms.

• Multicellular fungi feature complex, body-like thread structures called hyphae (a specialized detail relevant to Higher Tier study).

• A key example of a fungal pathogen is Rose black spot:

  • Rose black spot infects plants, causing dark black or purple spots to form on plant leaves.

  • These spots reduce the leaf area available to absorb light, thereby decreasing the overall rate of photosynthesis in the plant.

Protists

• Protists are predominantly single-celled eukaryotic organisms.

• The majority of pathogenic protists are biological parasites.

• Parasitic protists are typically transferred to a target host via a vector. A vector is an organism—such as a mosquito—that carries and transfers the protist pathogen from one source to another without contracting the disease itself.

• The primary example of a protist-borne disease is Malaria.

Prevention of Disease Transmission

The spread of communicable diseases can be managed and reduced through four main preventive measures:

• Hygiene Practices: Maintaining clean habits, such as thoroughly washing hands prior to food preparation or immediately following a sneeze, stops pathogen transfer.

• Vector Eradication: Suppressing or destroying vector populations breaks the transmission cycle. Methods include spraying insecticides or destroying breeding habitats (such as draining standing water where mosquitoes breed).

• Isolation Protocols: Physically separating infected individuals prevents pathogen exposure to healthy populations, a procedure widely utilized during outbreaks such as COVID-19.

• Vaccination and Herd Immunity: Administering vaccines builds systemic protection across a population, generating herd immunity.

  • Herd Immunity Scenario: Consider a group of $100$ people in a room where $60$ individuals are fully vaccinated against a specific pathogen. These $60$ vaccinated individuals form a biological protective wall surrounding the remaining unvaccinated individuals. Because the pathogen cannot infect or replicate within the vaccinated group, its transmission chain is blocked, providing indirect protection to the unvaccinated individuals.

Human Defense Systems against Infection

If preventative measures fail and pathogens enter the body, human physiology employs three distinct lines of defense to clear the infection.

First Line of Defense: Physical and Chemical Barriers

• Skin: Forms an outer physical barrier that blocks pathogen entry.

• Tears: Contain specialized antibacterial enzymes called lysozymes that break down cell walls (a specific concept for Higher Tier study).

• Nose and Ear Hairs: Physical structures and specialized cilia line these cavities to trap incoming physical particles and pathogens.

• Stomach Acid: The stomach produces hydrochloric acid at a high concentration, reaching an acidity of approximately $\text{pH } 2$. This extreme environment instantly kills ingested micro-organisms.

• Mucus: A sticky chemical lining present in the nose and throat that traps inhaled or ingested pathogens before they penetrate deeper internal tissues.

Second Line of Defense: Phagocytes

• Phagocytes are a specific functional class of white blood cells involved in non-specific immune responses.

• Pathogen Agglutination via Antibodies: Secreted antibodies attach to surface proteins on multiple pathogens simultaneously. For example, rather than requiring a phagocyte to chase down $10$ individual pathogens separately, antibodies stick all $10$ pathogens together into a single cluster.

• Phagocytosis: The phagocyte hunts down the pathogen cluster, engulfing and digesting all contained pathogens at once to eliminate the infection.

Third Line of Defense: Lymphocytes and Specific Immunity

• Lymphocytes are specialized white blood cells that coordinate specific immune memory alongside phagocytes.

• Antigens as Protein Identifiers: Antigens are small surface proteins located on the exterior of a pathogen. These proteins act as a unique molecular fingerprint that identifies the specific strain or type of pathogen.

• Memory Formation: When phagocytes digest a pathogen, lymphocytes analyze the distinct antigen structure to remember the pathogen's identity.

• Secondary Immune Response: If the same live pathogen enters the body at a later time, lymphocytes recognize the specific antigen immediately. The body responds by rapidly mass-producing specific antibodies to destroy the foreign pathogen before it can proliferate or cause symptomatic harm.

Mechanism of Vaccination

Vaccination builds targeted immunity against dangerous pathogens through a four-stage process:

1. Administration of Inactive Pathogen: A dead, weakened, or inactive form of a pathogen is introduced into the human body.

2. Induction of a Harmless Immune Response: Because the introduced pathogen is completely dead or inactive, it cannot cause symptomatic illness or physical damage. However, its unique surface antigens remain intact to stimulate host immune cells.

3. Antigen Recognition and Storage: White blood cells called phagocytes engulf the inactive pathogen. Lymphocytes identify the unique surface antigens, construct matching antibody templates, and retain this genetic memory.

4. Rapid Secondary Defense: If a live, virulent version of the pathogen enters the body in the future, the immune system recognizes the antigen instantly. Lymphocytes rapidly mass-produce the stored specific antibodies, destroying the pathogen and reducing host damage.

Drug Testing and Development Processes

To ensure safety, efficacy, and correct dosage, any new medical drug must undergo a formal four-stage evaluation process before being approved for general public use.

Stages of Drug Testing

1. Computer Modeling: The candidate chemical compound is modeled using specialized computer software based on biological data to predict structural interactions and biological activity in a virtual simulation.

2. In Vitro Cellular and Tissue Testing: The drug is introduced to living isolated cells and tissue samples in a laboratory setting. This stage monitors cellular responses and tests compatibility with specific organelles, such as mitochondria.

3. Preclinical Animal Testing: The drug is administered to live animals whose organ systems closely simulate human physiology to observe complex biological reactions.

4. Human Clinical Trials: The drug enters human trials, where it is administered to healthy and affected human volunteers under strict protocols using placebos and double-blind parameters.

Clinical Trial Protocols

• Placebo Control: A placebo is a dummy version of a drug (such as an inactive sugar sweet designed to match the real drug in size, shape, and taste) that contains no active pharmaceutical ingredient. It is used to separate genuine physiological responses from psychological effects (where a patient feels better simply because they believe they have taken active medicine).

  • Example: In a study group of $10$ trial participants, $5$ individuals receive the active therapeutic drug while $5$ individuals receive the inactive placebo sweet. If a participant given the sweet reports symptom improvement, that change is categorized as a psychological placebo effect.

• Double-Blind Trial Design: A study design in which neither the participating patients nor the supervising doctors know who receives the active medication and who receives the placebo. This setup completely eliminates observer bias and patient expectation bias from the trial results.

Evaluated Testing Parameters

• Efficacy: A measurement assessing how effectively the candidate medication treats or cures the targeted condition.

• Dosage: Determination of the exact concentration and administration frequency required for maximum therapeutic benefit.

• Toxicity: Assessment of harmful side effects or toxic reactions caused by the drug, guiding modifications to the chemical formula or lower limits on safe human exposure.